# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-25-019659
Filing Date
2025-04-24
Accepted
2025-04-24 16:03:12
Documents
22
Period of Report
2025-06-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | bcrx-20250424.htm iXBRL | DEF 14A | 1211252
6 |  | bcrx-20250424_g1.jpg | GRAPHIC | 22227
7 |  | bcrx-20250424_g2.jpg | GRAPHIC | 134096
8 |  | bcrx-20250424_g3.jpg | GRAPHIC | 115480
9 |  | bcrx-20250424_g4.jpg | GRAPHIC | 125548
10 |  | bcrx-20250424_g5.jpg | GRAPHIC | 155425
11 |  | bcrx-20250424_g6.jpg | GRAPHIC | 114420
| Complete submission text file | 0001628280-25-019659.txt |  | 3513020

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcrx-20250424.xsd | EX-101.SCH | 2355
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcrx-20250424_def.xml | EX-101.DEF | 2391
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcrx-20250424_lab.xml | EX-101.LAB | 2738
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcrx-20250424_pre.xml | EX-101.PRE | 1472
24 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx-20250424_htm.xml | XML | 108522

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 25867194
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)